
Min Zhang
Articles
-
Mar 27, 2025 |
frontiersin.org | Tingting Wang |Ling Ji |Jian Li |Min Zhang |Yanyan Hong |Sixuan Han
Background and aimsAlthough exercise performance is an essential tool for managing heart failure, there is still no consensus on whether exercise prescriptio...
-
Mar 17, 2025 |
cell.com | Xiangyu Deng |Lina Sun |Min Zhang |Rashmi Basavaraj |Jin Wang |Yi-Lan Weng | +1 more
KeywordsRNA editingADAR1cryo-EMAicardi-Goutières syndromeGet full text accessLog in, subscribe or purchase for full access. References1. Nishikura, K. A-to-I editing of coding and non-coding RNAs by ADARsNat. Rev. Mol. Cell Biol. 2016; 17:83-962. Song, B. ∙ Shiromoto, Y. ∙ Minakuchi, M. ... The role of RNA editing enzyme ADAR1 in human diseaseWIREs RNA. 2022; 13, e16653. Quin, J. ∙ Sedmík, J. ∙ Vukić, D. ... ADAR RNA modifications, the epitranscriptome and innate immunityTrends Biochem. Sci. 2021; 46:758-7714.
-
Mar 7, 2025 |
biorxiv.org | Min Zhang |Xiangyu Deng |Yang Gao |Jin Wang
AbstractWang et al. in Nature Cancer report ZYS-1 as an ADAR1 inhibitor and present biochemical and cellular evidence to support ZYS-1's direct interaction with and inhibition of ADAR1, including enzymatic assays, surface plasmon resonance (SPR), drug affinity responsive target stability (DARTS), and cellular thermal shift assays (CETSA). We raise critical methodological concerns regarding the validation of ZYS-1 as a bona fide ADAR1 inhibitor.
-
Feb 25, 2025 |
mdpi.com | Rong Fu |Min Zhang |Feng Wei |Miaomiao Lin
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Feb 25, 2025 |
mdpi.com | Min Zhang |Gaolei Qin |Pengfei Li |Xiangjie Zhang
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →